𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Controlled release using a new bioerodible polyphosphazene matrix system

✍ Scribed by Laurencin, C. T. ;Koh, H. J. ;Neenan, T. X. ;Allcock, H. R. ;Langer, Robert


Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
864 KB
Volume
21
Category
Article
ISSN
0021-9304

No coin nor oath required. For personal study only.

✦ Synopsis


Polyphosphazenes possess polymer backbones consisting of nitrogen and phosphorous formally separated by alternating single and double bonds. Their potential for biomedical applications stems from the fact that polymers with a wide array of properties can be synthesized using the same starting compound, poly(dich1orophosphazene), through changes in side chain substituents, and that many of these compounds synthesized have been found to biodegrade to harmless products. In this article, studies of a novel monolithic bioerodible polyphosphazene matrix system for controlled drug delivery are presented. Poly(imidazo1e methy1phenoxy)phosphazene is synthesized and shown to be bioerodible. The versatility of drug delivery devices fabricated using this polymer is shown through studies of release of macromolecules and low molecular weight drugs. Initial histological evaluations of this particular polyphosphazene are also presented.


πŸ“œ SIMILAR VOLUMES


A new drug delivery system with controll
✍ Suzuki, Yoshihisa ;Tanihara, Masao ;Nishimura, Yoshihiko ;Suzuki, Kyoko ;Kakimar πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 143 KB πŸ‘ 2 views

An ideal drug delivery system (DDS) releases an appropriate drug at specific locations and times. We tried to create a new antibiotic delivery system that releases gentamicin only when wounds are infected by Pseudomonas aeruginosa (P.A.). Exudate from the dorsal pouch of rats infected with P.A. show

Development of a new controlled-release
✍ Roger L. Williams; Robert A. Upton; Luann Ball; Richard L. Braun; Emil T. Lin; W πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 442 KB

Development of a controlled-released formulation of chlorpheniramine maleate is described, using in vitro/in vivo correlates, according to a process that has been termed "biorelevant dissolution". The process begins with simulations using several possible input rates combined with known disposition